Maryam Abbasi , M D | Authors


BCMA-Targeting Agents for the Treatment of Multiple Myeloma Take Hold

February 04, 2020

Across therapy vehicles, agents targeting the B-cell maturation antigen have emerged as promising potential therapies in the multiple myeloma treatment paradigm. Following the 2019 American Society of Hematology Annual Meeting & Exposition, experts reflect on what these new advances mean for the field of oncology care.